Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
Peijie Wu, Wei Gao, Miao Su, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 158

Showing 1-25 of 158 citing articles:

Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles
Ehsan Kianfar
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 320
Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A
Wei Gao, Zhao Huang, Jiufei Duan, et al.
Molecular Oncology (2021) Vol. 15, Iss. 12, pp. 3527-3544
Open Access | Times Cited: 212
Magnetic Nanoparticles in Targeted Drug Delivery: a Review
Ehsan Kianfar
Journal of Superconductivity and Novel Magnetism (2021) Vol. 34, Iss. 7, pp. 1709-1735
Closed Access | Times Cited: 183
Phytosomes as Innovative Delivery Systems for Phytochemicals: A Comprehensive Review of Literature
Mahmood Barani, Enrico Sangiovanni, M. Angarano, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 6983-7022
Open Access | Times Cited: 173
RNA modifications in physiology and disease: towards clinical applications
Sylvain Delaunay, Mark Helm, Michaela Frye
Nature Reviews Genetics (2023) Vol. 25, Iss. 2, pp. 104-122
Open Access | Times Cited: 117
Understanding and targeting resistance mechanisms in cancer
Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 107
Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery
Fatemeh Davodabadi, Seyedeh Fatemeh Sajjadi, Mohammad Sarhadi, et al.
European Journal of Pharmacology (2023) Vol. 958, pp. 176013-176013
Closed Access | Times Cited: 55
Targeting the tumor microenvironment: Potential strategy for cancer therapeutics
Quratulain Babar, Ayesha Saeed, Tanveer A. Tabish, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166746-166746
Open Access | Times Cited: 49
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 18
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges
Fakhara Sabir, Mahira Zeeshan, Ushna Laraib, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3396-3396
Open Access | Times Cited: 61
CO2 utilization for determining solubility of teriflunomide (immunomodulatory agent) in supercritical carbon dioxide: Experimental investigation and thermodynamic modeling
Gholamhossein Sodeifian, Loubna Nasri, Fariba Razmimanesh, et al.
Journal of CO2 Utilization (2022) Vol. 58, pp. 101931-101931
Closed Access | Times Cited: 50
The 2022 Report on the Human Proteome from the HUPO Human Proteome Project
Gilbert S. Omenn, Lydie Lane, Christopher M. Overall, et al.
Journal of Proteome Research (2022) Vol. 22, Iss. 4, pp. 1024-1042
Open Access | Times Cited: 46
Glioblastoma Microenvironment and Cellular Interactions
Carmen Crivii, Adina Bianca Boşca, Carmen Stanca Melincovici, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1092-1092
Open Access | Times Cited: 45
A tumor microenvironment-responsive poly(amidoamine) dendrimer nanoplatform for hypoxia-responsive chemo/chemodynamic therapy
Yingchao Hao, Yue Gao, Yu Fan, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 44
Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications
Peijie Wu, Jun Han, Yanju Gong, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 1990-1990
Open Access | Times Cited: 43
Identifying potential ligand–receptor interactions based on gradient boosted neural network and interpretable boosting machine for intercellular communication analysis
Lihong Peng, Pengfei Gao, Wei Xiong, et al.
Computers in Biology and Medicine (2024) Vol. 171, pp. 108110-108110
Closed Access | Times Cited: 11
Synergistic Effect of Ferroptosis‐Inducing Nanoparticles and X‐Ray Irradiation Combination Therapy
Chaewon Bae, Rodrigo Hernández Millares, Suhyun Ryu, et al.
Small (2024) Vol. 20, Iss. 19
Open Access | Times Cited: 9
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 9
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance
C. Raman Suri, Babita Pande, Lakkakula Suhasini Sahithi, et al.
Cancer Drug Resistance (2025)
Open Access | Times Cited: 1
Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells
Yali Fan, Quanmei Sun, Xia Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 54
Proteomics, Personalized Medicine and Cancer
Miao Su, Zhe Zhang, Li Zhou, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2512-2512
Open Access | Times Cited: 48
KRAS: A Druggable Target in Colon Cancer Patients
Francesca Negri, Lorena Bottarelli, Gian Luigi de’Angelis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4120-4120
Open Access | Times Cited: 37
Plasmid DNA for Therapeutic Applications in Cancer
David Hernán Martínez-Puente, José J. Pérez‐Trujillo, Laura Mireya Zavala-Flores, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1861-1861
Open Access | Times Cited: 34
Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications
Valérie Jacquemin, Mathieu Antoine, Geert Dom, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 280-280
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top